RIOT BLOCKCHAIN, INC.
Profile
Company Names
RIOT BLOCKCHAIN, INC.
BIOPTIX, INC.
VENAXIS, INC.
Addresses
202 6TH STREET, SUITE 401, CASTLE ROCK, CO 80104
1775 38TH STREET, BOULDER, CO 80301
1585 S. PERRY STREET, CASTLE ROCK, CO 80104
Phone Numbers
303-794-2000
303-545-5550
(303) 794-2000
Entity Type:
CORPORATION
Industry:
OTHER TECHNOLOGY, OTHER, BIOTECHNOLOGY, OTHER HEALTH CARE
Year Incorporated:
> 5 years ago
State Incorporated:
COLORADO
Total Amount Raised:
$53,047,660.00
Number of Funding Rounds:
5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2019-01-28
$7,060,132.00
$7,060,132.00
$0.00
Equity, Debt
4
2017-12-21
$37,037,528.00
$37,037,528.00
$0.00
Equity
3
2017-03-16
$4,750,000.00
$4,750,000.00
$0.00
Debt
2
2017-03-10
$2,250,000.00
$2,250,000.00
$0.00
Equity
1
2016-09-12
$1,950,000.00
$1,950,000.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
ANDREW
KAPLAN
DIRECTOR
A TO B CAPITAL SPECIAL SITUATIONS FUND LP
| SC ACADEMY HOLDINGS, INC.
| PV OPPORTUNITY FUND II, LP
| NAKED BRAND GROUP INC.
| ASPEN GROUP, INC.
| GLOBALORIA, LLC
| MODO LABS, INC.
| RIOT BLOCKCHAIN, INC.
| ELOCAL USA LLC
| BVO HOLDINGS, LLC
| EDUCATION GROWTH PARTNERS, LP
| U.S. GOLD CORP.
| USRC PARTNER HOLDINGS, L.P.
| SHERMAN THEATRICAL ENTERTAINMENT LTD.
| BCPE OCEANDRIVE HOLDINGS, LP
| EDUCATION GROWTH PARTNERS II, L.P.
| NAKED REVIVAL INC.
| KANGAROOTIME, INC.
| VIVVI, INC.
REMO
MANCINI
EXECUTIVE OFFICER
JEFFREY
G.
MCGONEGAL
EXECUTIVE OFFICER
ERIC
SO
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER TECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity, Debt
2019-01-28
D
OTHER
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2017-12-21
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Debt
2017-03-16
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2017-03-10
D
OTHER HEALTH CARE
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2016-09-12
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

